Variant report

Variant	esv3372799
Chromosome Location	chr20:1167052-1171250
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:132)
CpG islands
(count:61)
Chromatin interactive
region (count:8)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:132 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr20:1168114-1169213	K562	blood:	n/a	n/a
2	ARID3A	chr20:1168208-1169267	HepG2	liver:	n/a	n/a
3	ATF1	chr20:1168128-1168845	K562	blood:	n/a	n/a
4	BHLHE40	chr20:1168096-1168852	K562	blood:	n/a	n/a
5	BRCA1	chr20:1167369-1167388	HepG2	liver:	n/a	n/a
6	BRCA1	chr20:1168342-1168623	HepG2	liver:	n/a	n/a
7	CBX3	chr20:1168081-1168752	K562	blood:	n/a	n/a
8	CCNT2	chr20:1168183-1168823	K562	blood:	n/a	n/a
9	CEBPB	chr20:1168269-1168856	K562	blood:	n/a	n/a
10	CEBPB	chr20:1168462-1168881	HepG2	liver:	n/a	n/a
11	CEBPB	chr20:1168231-1168893	K562	blood:	n/a	n/a
12	CEBPD	chr20:1168165-1168910	K562	blood:	n/a	n/a
13	CHD1	chr20:1168113-1168161	H1-hESC	embryonic stem cell:	n/a	n/a
14	CHD2	chr20:1168381-1168641	K562	blood:	n/a	n/a
15	CHD2	chr20:1167070-1167706	HepG2	liver:	n/a	n/a
16	CTCF	chr20:1166960-1167350	HepG2	liver:	n/a	n/a
17	CTCF	chr20:1169081-1169309	GM19239	blood:	n/a	n/a
18	CTCF	chr20:1166960-1167110	GM12873	blood:	n/a	n/a
19	CTCF	chr20:1167220-1167370	HEK293	kidney:	n/a	n/a
20	CTCF	chr20:1167080-1167230	HVMF	connective:	n/a	n/a
21	CTCF	chr20:1169108-1169259	MCF-7	breast:	n/a	n/a
22	CTCF	chr20:1167300-1167450	SAEC	small airway:	n/a	chr20:1167418-1167427
23	CTCF	chr20:1167056-1167078	GM10248	blood:	n/a	n/a
24	CTCF	chr20:1166101-1167263	A549	lung:	n/a	chr20:1166567-1166585 chr20:1166162-1166175
25	CTCF	chr20:1167240-1167390	HCPEpiC	choroid plexus:	n/a	n/a
26	CTCF	chr20:1166940-1167090	HBMEC	blood vessel:	n/a	n/a
27	CUX1	chr20:1168182-1168840	K562	blood:	n/a	n/a
28	ELF1	chr20:1168103-1168609	K562	blood:	n/a	chr20:1168360-1168373
29	ELF1	chr20:1168418-1168728	HepG2	liver:	n/a	n/a
30	ELK1	chr20:1168369-1168572	K562	blood:	n/a	n/a
31	EP300	chr20:1168155-1168843	K562	blood:	n/a	n/a
32	EP300	chr20:1168399-1168776	HepG2	liver:	n/a	n/a
33	EP300	chr20:1168328-1168812	HepG2	liver:	n/a	n/a
34	EP300	chr20:1169383-1169453	K562	blood:	n/a	n/a
35	EP300	chr20:1167202-1167303	HepG2	liver:	n/a	n/a
36	EP300	chr20:1168376-1168749	GM12878	blood:	n/a	n/a
37	EP300	chr20:1168319-1168835	HepG2	liver:	n/a	n/a
38	EP300	chr20:1167541-1167741	HepG2	liver:	n/a	n/a
39	EP300	chr20:1168131-1169161	K562	blood:	n/a	n/a
40	GATA1	chr20:1168146-1169077	PBDE	blood:	n/a	n/a
41	GATA1	chr20:1167588-1169589	K562	blood:	n/a	n/a
42	GATA2	chr20:1168358-1168768	SH-SY5Y	brain:	n/a	n/a
43	GATA2	chr20:1168230-1169347	K562	blood:	n/a	n/a
44	GATA2	chr20:1168133-1168901	K562	blood:	n/a	n/a
45	GATA3	chr20:1168567-1168754	SH-SY5Y	brain:	n/a	n/a
46	HCFC1	chr20:1168209-1168786	K562	blood:	n/a	n/a
47	HDAC2	chr20:1168244-1168712	HepG2	liver:	n/a	n/a
48	HMGN3	chr20:1168234-1168967	K562	blood:	n/a	n/a
49	HNF4A	chr20:1168328-1168790	HepG2	liver:	n/a	chr20:1168587-1168602
50	HNF4A	chr20:1168320-1168725	HepG2	liver:	n/a	chr20:1168587-1168602

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr20:1169960-1170010	GM12878	blood:	n/a
2	chr20:1169960-1170010	IMR90	lung:	fetal
3	chr20:1169960-1170010	Hepatocyte	liver:	n/a
4	chr20:1169960-1170010	NT2-D1	testis:	n/a
5	chr20:1169960-1170010	HL-60	blood:	n/a
6	chr20:1169960-1170010	SK-N-SH	brain:	n/a
7	chr20:1169960-1170010	NH-A	brain:	n/a
8	chr20:1169960-1170010	GM06990	blood:	n/a
9	chr20:1169960-1170010	SKMC	muscle:	n/a
10	chr20:1169960-1170010	HEK293	kidney:	embryo
11	chr20:1169960-1170010	HUVEC	blood vessel:	n/a
12	chr20:1169960-1170010	T-47D	breast:	n/a
13	chr20:1169960-1170010	MCF10A-Er-Src	breast:	n/a
14	chr20:1169960-1170010	Hela-S3	cervix:	n/a
15	chr20:1169960-1170010	SAEC	small airway:	n/a
16	chr20:1169960-1170010	ProgFib	skin:	n/a
17	chr20:1169960-1170010	CMK	blood:	n/a
18	chr20:1169960-1170010	SK-N-SH_RA	brain:	n/a
19	chr20:1169960-1170010	HNPCEpiC	eye:	n/a
20	chr20:1169960-1170010	A549	lung:	n/a
21	chr20:1169960-1170010	GM12891	blood:	n/a
22	chr20:1169960-1170010	NHBE	bronchial:	n/a
23	chr20:1169960-1170010	NHDF-neo	bronchial:	n/a
24	chr20:1169960-1170010	AG09309	skin:	n/a
25	chr20:1169960-1170010	ECC-1	luminal epithelium:	n/a
26	chr20:1169960-1170010	AG04450	lung:	fetal
27	chr20:1169960-1170010	BE2_C	brain:	n/a
28	chr20:1169960-1170010	AoSMC	blood vessel:	n/a
29	chr20:1169960-1170010	HepG2	liver:	n/a
30	chr20:1169960-1170010	PrEC	prostate:	n/a
31	chr20:1169960-1170010	ovcar-3	ovarian:	n/a
32	chr20:1169960-1170010	MCF-7	breast:	n/a
33	chr20:1169960-1170010	HRCEpiC	kidney:	n/a
34	chr20:1169960-1170010	PFSK-1	brain:	n/a
35	chr20:1169960-1170010	HEEpiC	esophagus:	n/a
36	chr20:1169960-1170010	HCM	heart:	n/a
37	chr20:1169960-1170010	H1-hESC	embryonic stem cell:	embryo
38	chr20:1169960-1170010	K562	blood:	n/a
39	chr20:1169960-1170010	HIPEpiC	eye:	n/a
40	chr20:1169960-1170010	NB4	blood:	n/a
41	chr20:1169960-1170010	LNCaP	prostate:	n/a
42	chr20:1169960-1170010	SK-N-MC	brain:	n/a
43	chr20:1169960-1170010	GM12892	blood:	n/a
44	chr20:1169960-1170010	RPTEC	kidney:	n/a
45	chr20:1169960-1170010	AG10803	skin:	n/a
46	chr20:1169960-1170010	HPAEpiC	pulmonary alveolar:	n/a
47	chr20:1169960-1170010	BJ	skin:	n/a
48	chr20:1169960-1170010	HRE	kidney:	n/a
49	chr20:1169960-1170010	AG04449	skin:	fetal
50	chr20:1169960-1170010	HCF	heart:	n/a

(count:8 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr20:1160009..1162327-chr20:1170568..1173359,2	K562	blood:
2	chr20:1163614..1165448-chr20:1169963..1171650,2	K562	blood:
3	chr20:796367..797247-chr20:1166167..1167087,2	K562	blood:
4	chr20:1169038..1170828-chr20:1174673..1177057,2	K562	blood:
5	chr20:1166329..1168074-chr20:1189249..1191383,2	K562	blood:
6	chr20:1168079..1170501-chr20:1189390..1192354,2	K562	blood:
7	chr20:1167926..1170503-chr20:1170945..1173932,3	K562	blood:
8	chr20:1167926..1170503-chr20:1170945..1173932,3	K562	blood:

No data

Variant related genes	Relation type
TMEM74B	TF binding region
TMEM74B	CpG island
ENSG00000125895	chromatin interactions

Extended variants
information (count: 188 )
Associated
traits (count: 63 )

Variant overlapped rSNPs/rCNVs (count:188 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs553407571	chr20:1167066-1167067	Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs186921085	chr20:1167076-1167077	Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs548425347	chr20:1167091-1167092	Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs545455852	chr20:1167103-1167104	Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs372420404	chr20:1167179-1167180	Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs562423777	chr20:1167190-1167191	Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs375446234	chr20:1167200-1167201	Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs117418234	chr20:1167233-1167234	Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs13042590	chr20:1167239-1167240	Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs145921233	chr20:1167253-1167254	Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs561513845	chr20:1167287-1167288	Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs13042734	chr20:1167320-1167321	Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription Genic enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs6108843	chr20:1167390-1167391	Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs6108844	chr20:1167434-1167435	Active TSS Bivalent Enhancer Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs142758258	chr20:1167458-1167459	Active TSS Bivalent Enhancer Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs566937964	chr20:1167479-1167480	Active TSS Bivalent Enhancer Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs532616647	chr20:1167548-1167549	Active TSS Bivalent Enhancer Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs552322378	chr20:1167551-1167552	Active TSS Bivalent Enhancer Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs79751132	chr20:1167565-1167566	Active TSS Bivalent Enhancer Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs537795775	chr20:1167566-1167567	Active TSS Bivalent Enhancer Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs147366845	chr20:1167570-1167571	Active TSS Bivalent Enhancer Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs374692500	chr20:1167576-1167577	Active TSS Bivalent Enhancer Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs6108846	chr20:1167611-1167612	Active TSS Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs79597391	chr20:1167621-1167622	Active TSS Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs191816299	chr20:1167649-1167650	Active TSS Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs553474881	chr20:1167652-1167653	Active TSS Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs576896003	chr20:1167673-1167674	Active TSS Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs545869566	chr20:1167679-1167680	Active TSS Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs183588267	chr20:1167685-1167686	Active TSS Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs148409120	chr20:1167706-1167707	Active TSS Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs544925380	chr20:1167710-1167711	Active TSS Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs561525865	chr20:1167715-1167716	Active TSS Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs189632645	chr20:1167758-1167759	Active TSS Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs181919195	chr20:1167774-1167775	Active TSS Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs34640116	chr20:1167796-1167797	Active TSS Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs73577437	chr20:1167808-1167809	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs373121082	chr20:1167938-1167939	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs552636302	chr20:1167941-1167942	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs559358730	chr20:1167945-1167946	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs562740418	chr20:1167955-1167956	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs531689281	chr20:1167976-1167977	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs548091557	chr20:1168003-1168004	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs567982818	chr20:1168015-1168016	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs533817199	chr20:1168042-1168043	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs565425699	chr20:1168071-1168072	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs185758527	chr20:1168135-1168136	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs114233641	chr20:1168158-1168159	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs77333659	chr20:1168231-1168232	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs141611672	chr20:1168233-1168234	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs377506027	chr20:1168236-1168237	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:63)

Disease	PMID	Source
Hodgkin''s lymphoma	18641027	CNVD
Myelofibrosis	22110671	CNVD
Intellectual disability	22045946	CNVD
Glioblastoma multiforme	22286061	CNVD
Hepatocellular carcinoma	22174799	CNVD
Colorectal cancer	19455253	CNVD
Ovarian cancer	20844748	CNVD
Breast cancer	17603634	CNVD
Colorectal cancer	19359472	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Intracranial aneurysm	16715129	CNVD
Colorectal cancer	16774939	CNVD
Autism	18414403	CNVD
Neurocytoma	17123091	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16397240	CNVD
abortions and stillbirths	19751515	CNVD
Wilms tumour	21544195	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	16272173	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	19627613	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Central neurocytomas	17123091	CNVD
Colorectal cancer	16272173	CNVD
Gastric cancer	17908304	CNVD
Urothelial carcinoma	21177765	CNVD
lymphocytic leukemia	21291569	CNVD
Acute myeloid leukemia	20729466	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Ewing''s sarcoma	17952124	CNVD
Oral cancer	21386901	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Colorectal cancer	21645411	CNVD
small cell lung cancer	20016488	CNVD
Melanoma	17363583	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:127 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr20:1166000-1169000	Weak transcription	Gastric	stomach
2	chr20:1166200-1167400	Bivalent Enhancer	Placenta	Placenta
3	chr20:1166400-1167200	Weak transcription	Esophagus	oesophagus
4	chr20:1166400-1167400	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
5	chr20:1166400-1167800	Bivalent Enhancer	Fetal Muscle Leg	muscle
6	chr20:1166400-1168400	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
7	chr20:1166400-1169000	Weak transcription	Pancreas	Pancrea
8	chr20:1166400-1169000	Enhancers	Sigmoid Colon	Sigmoid Colon
9	chr20:1166400-1169400	Enhancers	Lung	lung
10	chr20:1166600-1167200	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
11	chr20:1166600-1167200	Bivalent Enhancer	Rectal Mucosa Donor 29	rectum
12	chr20:1166600-1167400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
13	chr20:1166600-1167400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
14	chr20:1166600-1167400	Flanking Bivalent TSS/Enh	HepG2	liver
15	chr20:1166600-1168200	Weak transcription	Left Ventricle	heart
16	chr20:1166600-1168200	Enhancers	Small Intestine	intestine
17	chr20:1166600-1169200	Enhancers	Right Atrium	heart
18	chr20:1166800-1167200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
19	chr20:1166800-1167200	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
20	chr20:1166800-1167200	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
21	chr20:1166800-1167200	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
22	chr20:1166800-1167400	Enhancers	H9 Cell Line	embryonic stem cell
23	chr20:1166800-1167400	Bivalent Enhancer	Fetal Lung	lung
24	chr20:1166800-1167400	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
25	chr20:1166800-1167400	Enhancers	Spleen	Spleen
26	chr20:1166800-1167600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
27	chr20:1166800-1167600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
28	chr20:1166800-1167800	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
29	chr20:1166800-1167800	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
30	chr20:1166800-1168000	Weak transcription	Pancreatic Islets	Pancreatic Islet
31	chr20:1166800-1168600	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
32	chr20:1166800-1169400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
33	chr20:1166800-1169400	Enhancers	Liver	Liver
34	chr20:1166800-1169400	Enhancers	Fetal Intestine Small	intestine
35	chr20:1167000-1167200	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
36	chr20:1167000-1167200	Flanking Bivalent TSS/Enh	Adipose Nuclei	Adipose
37	chr20:1167000-1167400	Weak transcription	Right Ventricle	heart
38	chr20:1167000-1167800	Active TSS	ES-WA7 Cell Line	embryonic stem cell
39	chr20:1167000-1167800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
40	chr20:1167000-1167800	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
41	chr20:1167000-1167800	Enhancers	K562	blood
42	chr20:1167000-1168200	Enhancers	A549	lung
43	chr20:1167000-1168200	Weak transcription	Hela-S3	cervix
44	chr20:1167000-1168600	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
45	chr20:1167000-1168600	Bivalent Enhancer	Duodenum Smooth Muscle	Duodenum
46	chr20:1167000-1169200	Enhancers	Rectal Mucosa Donor 31	rectum
47	chr20:1167000-1169400	Enhancers	Duodenum Mucosa	Duodenum
48	chr20:1167000-1169400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
49	chr20:1167000-1169400	Enhancers	Fetal Intestine Large	intestine
50	chr20:1167000-1169400	Enhancers	Stomach Mucosa	stomach

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links